Literature DB >> 822805

[Sphingolipid storage disease as an example of a molecular neuropathology (author's transl)].

H Jatzkewitz, K Sandhoff.   

Abstract

A short survey on the sphingolipid storage diseases is presented. The chemical nature of the accumulated substances is related to the genetically induced enzymic blocks on their biodegradation. Two disorders are stressed with alter the nervous system: metachromatic leukodystrophy and familiar infantile amaurotic idiocy (GM2-gangliosidosis). The difficulties in the causal interpretation of three variants of the latter disease due to the involvement of isoenzymes are dealt with. The relationship between the enzyme defect in these disorders and their time of clinical onset is discussed. Finally, the diagnostic possibilities are presented which are a prerequisite for preventing a further dissemination of these therapy-resistent inborn errors of metabolism.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 822805     DOI: 10.1007/BF00418481

Source DB:  PubMed          Journal:  Arch Psychiatr Nervenkr (1970)


  18 in total

1.  Subunit structure of human hexosaminidase verified: interconvertibility of hexosaminidase isozymes.

Authors:  E Beutler; W Kuhl
Journal:  Nature       Date:  1975-11-20       Impact factor: 49.962

Review 2.  Multiple human hexosaminidases.

Authors:  K Sandhoff
Journal:  Birth Defects Orig Artic Ser       Date:  1973-03

3.  Isoenzymes of sphingomyelinase and the genetic defect in Niemann-Pick disease, type C.

Authors:  J W Callahan; M Khalil; J Gerrie
Journal:  Biochem Biophys Res Commun       Date:  1974-05-20       Impact factor: 3.575

4.  Genetic complementation after fusion of Tay-Sachs and Sandhoff cells.

Authors:  G H Thomas; H A Taylor; C S Miller; J Axelman; B R Migeon
Journal:  Nature       Date:  1974-08-16       Impact factor: 49.962

5.  Tay-Sachs and Sandhoff's disease: intergenic complementation after somatic cell hybridization.

Authors:  H Galjaard; A Hoogeveen; H A de Wit-Verbeek; A J Reuser; W Keijzer; A Westerveld; D Bootsma
Journal:  Exp Cell Res       Date:  1974-08       Impact factor: 3.905

Review 6.  [Cerebral sphingolipidoses as inborn errors of metabolism].

Authors:  H Jatzkewitz
Journal:  Dtsch Med Wochenschr       Date:  1970-01-16       Impact factor: 0.628

7.  [Enrichment and characterization of 2 forms of human N-acetyl-beta-D-hexosaminidase].

Authors:  K Sandhoff; W Wässle
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1971-08

8.  A correlation of intracellular cerebroside sulfatase activity in fibroblasts with latency in metachromatic leukodystrophy.

Authors:  M T Porter; A L Fluharty; J Trammell; H Kihara
Journal:  Biochem Biophys Res Commun       Date:  1971-08-06       Impact factor: 3.575

9.  [Juvenile GM2 gangliosidosis with altered substrate specificity of hexosaminidase A (author's transl)].

Authors:  J Zerfowski; K Sandhoff
Journal:  Acta Neuropathol       Date:  1974-03-26       Impact factor: 17.088

10.  Sphingolipidoses.

Authors:  K Sandhoff
Journal:  J Clin Pathol Suppl (R Coll Pathol)       Date:  1974
View more
  1 in total

Review 1.  Basic findings and current developments in sphingolipidoses.

Authors:  H Pilz; R Heipertz; D Seidel
Journal:  Hum Genet       Date:  1979-03-12       Impact factor: 4.132

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.